echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Unexpected!

    Unexpected!

    • Last Update: 2022-01-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    "Smell" seems to be the patent of the nose, but in recent years, studies have found that it is not only the epidermal cells of the nasal cavity that have olfactory receptors


    Now, a new study published in Science links olfactory receptors in arteries to cardiovascular disease: On the walls of blood vessels, macrophage olfactory receptors "smell" the odorant molecule octanal and then Causes an inflammatory response that can lead to heart disease and atherosclerosis


    To our noses, octanal is a molecule with a distinct smell


    Octanal is a product of fatty acid peroxidation in the arterial wall under conditions of oxidative stress.


    In the past two years of research, scientists at the La Jolla Institute for Immunology have successively found that macrophages in the blood vessel wall also contain some olfactory receptors that can "smell" molecules; and the presence of the olfactory receptor OR6A2 makes the These macrophages can "smell" octanal


    To examine how octanal ultimately affects the risk of cardiovascular disease, the team injected octanal into the blood of normal mice and into the blood of gene-edited mice that had deleted the gene for the Olfr2 receptor, the human equivalent of OR6A2


    Subsequent studies further revealed the cause of the inflammatory response: when the Olfr2 receptor "smells" octanal, it induces activation of the NLRP3 inflammasome, which in turn produces more pro-inflammatory cytokines, interleukin-1β , accelerates atherosclerosis


    ▲ The mechanism by which Olfr2 receptors ultimately accelerate atherosclerosis (Image source: Reference [2])

    At the same time, the discovery of this signaling pathway also provides scientists with new ideas for inhibiting and reversing arterial damage


    The research team used citral, a lemon-flavored molecule that blocks olfactory receptors in mice


    The researchers believe that this process may also be achieved in humans, thereby blocking the OR6A2 receptor


    For these scientists, the study found more than just a potential avenue for cardiovascular disease prevention


    Note: The original text has been deleted

    References:

    [1] Marco Orecchioni et al.


    [2] Katey J.


    [3] Macrophages in the artery wall 'smell' their surroundings.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.